Andrew T. Magis

7.5k citations

65 papers · 3.1k indexed · 1 hit paper · h-index 28

Co-authors: Nathan D. Price Jennifer C. Lovejoy Sean M. Gibbons Ohad Manor David A. Ostrov Chengzhen L. Dai Sergey A. Kornilov William G. Cance
Topics: Cell Adhesion Molecules Research (12 papers)Gut microbiota and health (9 papers)Metabolomics and Mass Spectrometry Studies (8 papers)
Cited by: Immunology and Allergy Biological Psychiatry Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States United Kingdom South Korea

In The Last Decade

Andrew T. Magis

61 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Health and disease markers correlate with gut microbiome composition across thousands of people

2020 550 citations Ohad Manor, Chengzhen L. Dai et al. Nature Communications profile →

Peers

Countries citing papers authored by Andrew T. Magis

Since Specialization

Citations

This map shows the geographic impact of Andrew T. Magis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew T. Magis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew T. Magis more than expected).

Fields of papers citing papers by Andrew T. Magis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew T. Magis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew T. Magis. The network helps show where Andrew T. Magis may publish in the future.

Co-authorship network of co-authors of Andrew T. Magis

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew T. Magis. A scholar is included among the top collaborators of Andrew T. Magis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew T. Magis. Andrew T. Magis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention 2023 ·Nature Medicine ·Kengo Watanabe,Tomasz Wilmanski,Christian Diener,John C. Earls,Anat Zimmer,(unknown),Jennifer Hadlock,Jennifer C. Lovejoy,Sean M. Gibbons,Andrew T. Magis,Leroy Hood,Nathan D. Price,Noa Rappaport	71
2	Genome–microbiome interplay provides insight into the determinants of the human blood metabolome 2022 ·Nature Metabolism ·Christian Diener,Chengzhen L. Dai,Tomasz Wilmanski,Priyanka Baloni,Brett Smith,Noa Rappaport,Leroy Hood,Andrew T. Magis,Sean M. Gibbons	59
3	The geometry of clinical labs and wellness states from deeply phenotyped humans 2021 ·Nature Communications ·Anat Zimmer,Yael Korem,Noa Rappaport,Tomasz Wilmanski,Priyanka Baloni,(unknown),Max Robinson,Andrew T. Magis,Jennifer C. Lovejoy,Sean M. Gibbons,Leroy Hood,Nathan D. Price	10
4	Characteristics and Factors Associated With Coronavirus Disease 2019 Infection, Hospitalization, and Mortality Across Race and Ethnicity 2021 ·Clinical Infectious Diseases ·Chengzhen L. Dai,Sergey A. Kornilov,Ryan Roper,Hannah Cohen‐Cline,(unknown),Brett Smith,James R. Heath,George Diaz,Jason D. Goldman,Andrew T. Magis,Jennifer Hadlock	39
5	DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk 2021 ·Journal of Clinical Investigation ·Helmut Grasberger,Andrew T. Magis,(unknown),Matthew P. Conomos,Min Zhang,(unknown),Guoqing Hou,Shrinivas Bishu,Hiroko Nagao‐Kitamoto,Mohamad El‐Zaatari,Sho Kitamoto,Nobuhiko Kamada,Ryan W. Stidham,Yasutada Akiba,Jonathan D. Kaunitz,Yael Haberman,Subra Kugathasan,Lee A. Denson,Gilbert S. Omenn,John Y. Kao	42
6	Multiomic blood correlates of genetic risk identify presymptomatic disease alterations 2020 ·Proceedings of the National Academy of Sciences ·Michael Wainberg,Andrew T. Magis,John C. Earls,Jennifer C. Lovejoy,Nasa Sinnott-Armstrong,Gilbert S. Omenn,Leroy Hood,Nathan D. Price	21
7	Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19 2020 ·Critical Care ·Sergey A. Kornilov,(unknown),(unknown),Chengzhen L. Dai,Jennifer C. Lovejoy,Andrew T. Magis	55
8	Longitudinal analysis reveals transition barriers between dominant ecological states in the gut microbiome 2020 ·Proceedings of the National Academy of Sciences ·Roie Levy,Andrew T. Magis,John C. Earls,Ohad Manor,Tomasz Wilmanski,Jennifer C. Lovejoy,Sean M. Gibbons,Gilbert S. Omenn,Leroy Hood,Nathan D. Price	44
9	Untargeted longitudinal analysis of a wellness cohort identifies markers of metastatic cancer years prior to diagnosis 2020 ·Scientific Reports ·Andrew T. Magis,Noa Rappaport,Matthew P. Conomos,Gilbert S. Omenn,Jennifer C. Lovejoy,Leroy Hood,Nathan D. Price	15
10	Mcl-1 Interacts with Akt to Promote Lung Cancer Progression 2019 ·Cancer Research ·Guo Chen,Dongkyoo Park,Andrew T. Magis,Madhusmita Behera,Suresh S. Ramalingam,Taofeek K. Owonikoko,Gabriel Sica,Keqiang Ye,Chao Zhang,Zhengjia Chen,Walter J. Curran,Xingming Deng	27
11	Genetic Predisposition Impacts Clinical Changes in a Lifestyle Coaching Program 2019 ·Scientific Reports ·Niha Zubair,Matthew P. Conomos,Leroy Hood,Gilbert S. Omenn,Nathan D. Price,Bonnie Spring,Andrew T. Magis,Jennifer C. Lovejoy	33
12	Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy 2015 ·Cancer Cell ·(unknown),Dongkyoo Park,Rui Li,Maohua Xie,Taofeek K. Owonikoko,Guojing Zhang,Gabriel Sica,Chunyong Ding,Jia Zhou,Andrew T. Magis,Zhuo G. Chen,Dong M. Shin,Suresh S. Ramalingam,Fadlo R. Khuri,Walter J. Curran,Xingming Deng	96
13	Detection of 1α,25-Dihydroxyvitamin D-Regulated miRNAs in Zebrafish by Whole Transcriptome Sequencing 2014 ·Zebrafish ·Theodore A. Craig,Yuji Zhang,Andrew T. Magis,Cory C. Funk,Nathan D. Price,Stephen C. Ekker,Rajiv Kumar	10
14	Novel Small-Molecule Inhibitors of Bcl-XL to Treat Lung Cancer 2013 ·Cancer Research ·Dongkyoo Park,Andrew T. Magis,Rui Li,Taofeek K. Owonikoko,Gabriel Sica,Shi‐Yong Sun,Suresh S. Ramalingam,Fadlo R. Khuri,Walter J. Curran,Xingming Deng	59
15	AUREA: an open-source software system for accurate and user-friendly identification of relative expression molecular signatures 2013 ·BMC Bioinformatics ·John C. Earls,James A. Eddy,Cory C. Funk,Younhee Ko,Andrew T. Magis,Nathan D. Price	4
16	Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo 2013 ·Anti-Cancer Agents in Medicinal Chemistry ·Deniz A. Uçar,Andrew T. Magis,(unknown),Nicholas J. Lawrence,Saı̈d M. Sebti,Elena Kurenova,Maria Zajac‐Kaye,Jianliang Zhang,Steven N. Hochwald	25
17	A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl) -3, 5, 7-triaza-1-azoniatricyclo [3.3.1.13,7]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo 2012 ·Carcinogenesis ·Vita Golubovskaya,Sheila Figel,B. T. HO,Colin P. Johnson,(unknown),Grace C. Huang,Min Zheng,Carl Nyberg,Andrew T. Magis,David A. Ostrov,Irwin H. Gelman,William G. Cance	78
18	Structure-Function Correlation of G6, a Novel Small Molecule Inhibitor of Jak2 2010 ·Journal of Biological Chemistry ·Anurima Majumder,L. Govindasamy,Andrew T. Magis,Róbert Kiss,Tímea Polgár,Rebekah Baskin,Robert W. Allan,Mavis Agbandje‐McKenna,Gary W. Reuther,György M. Keserű,Kirpal S. Bisht,Peter P. Sayeski	10
19	A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer 2009 ·Cell Cycle ·Steven N. Hochwald,Carl Nyberg,Min Zheng,Donghang Zheng,(unknown),Nicole Massoll,Andrew T. Magis,David A. Ostrov,William G. Cance,Vita Golubovskaya	130
20	Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth 2008 ·Molecular Cancer Therapeutics ·Jacqueline Sayyah,Andrew T. Magis,David A. Ostrov,Robert W. Allan,Raul C. Braylan,Peter P. Sayeski	20

About Andrew T. Magis

Andrew T. Magis is a scholar working on Immunology and Allergy, Biological Psychiatry and Oncology, having authored 65 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (12 papers), Gut microbiota and health (9 papers) and Metabolomics and Mass Spectrometry Studies (8 papers). The work is most often cited by research in Immunology and Allergy (395 citations), Biological Psychiatry (79 citations) and Molecular Biology (2.0k citations). Andrew T. Magis has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Nathan D. Price, Jennifer C. Lovejoy, Sean M. Gibbons, Ohad Manor, David A. Ostrov, Chengzhen L. Dai, Sergey A. Kornilov, William G. Cance, Brett Smith and Leroy Hood. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact